More Articles

EU guidelines for biosimilars Guidelines | Posted 08/10/2010

Last update: 8 January 2016The regulatory body for approval of medicines in the European Union (EU) is the European Medicines Agency (EMA). The agency is responsible for the scientific evaluation o...

Pharmacists could save the NHS GBP 1 billion Reports | Posted 01/10/2010

More than GBP 1 billion could be saved by the National Health Service (NHS) through better use of pharmacists in improving outcomes in public health and long-term conditions, a new report claims.

AstraZeneca expands its generics business with Indian agreements Pharma News | Posted 01/10/2010

In line with its continued mission to supply branded generics to emerging markets, such as Africa and Latin America, AstraZeneca has entered into yet another agreement with an Indian generics firm.

Epoetin alfa and pure red cell aplasia Biosimilars/Research | Posted 01/10/2010

Most therapeutic proteins have the potential to induce an immune response. Cases of pure red cell aplasia (PRCA) were reported after the formulation of Eprex (epoetin alfa) was changed. It is now k...

Incentives to use generic medicines Generics/Research | Posted 01/10/2010

A variety of financial and non-financial incentives are intended to encourage generic prescribing. Physician budgets are used by Germany and UK and seem to encourage generic prescribing. Assistance...

An industry view of generic manufacturing Generics/Research | Posted 01/10/2010

Research and development of innovative medicines are becoming more challenging, with only 29 medicines with new chemical entities launched in 2006. The dwindling pipeline of new innovative medicine...

Pricing strategies in generic medicines Generics/Research | Posted 01/10/2010

Eighty two per cent of countries impose pricing regulation while 18% opt for free market competition to control prices. Of the countries that regulate prices, 36% set the price of generic medicines...

Generics in The Netherlands Generics/General | Posted 01/10/2010

The market for generic medicines in The Netherlands ambulatory health care is developing, with more being used, more companies supplying generic medicines and prices tumbling. This is despite the r...